ES2069030T3 - Metodo para tratar funcionamiento defectuoso del corazon. - Google Patents

Metodo para tratar funcionamiento defectuoso del corazon.

Info

Publication number
ES2069030T3
ES2069030T3 ES90313614T ES90313614T ES2069030T3 ES 2069030 T3 ES2069030 T3 ES 2069030T3 ES 90313614 T ES90313614 T ES 90313614T ES 90313614 T ES90313614 T ES 90313614T ES 2069030 T3 ES2069030 T3 ES 2069030T3
Authority
ES
Spain
Prior art keywords
dealing
defective heart
heart operation
hif
injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90313614T
Other languages
English (en)
Inventor
Garner Haupert Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Application granted granted Critical
Publication of ES2069030T3 publication Critical patent/ES2069030T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Steroid Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Laser Surgery Devices (AREA)

Abstract

ESTA INVENCION PROPORCIONA UNA COMPOSICION FARMACEUTICA QUE COMPRENDE EL FACTOR INHIBITORIO HIPOTALAMICO (HIF) Y EL USO DE UN HIF PARA EL TRATAMIENTO DEL MAL FUNCIONAMIENTO CARDIACO, INTOXICACION DE GLICOSIDO CARDIACO, HIPOTENSION, DESORDENES EDEMATICOS Y PARA LA INMUNIZACION ACTIVA EN EL TRATAMIENTO DE LA HIPERTENSION.
ES90313614T 1989-12-13 1990-12-13 Metodo para tratar funcionamiento defectuoso del corazon. Expired - Lifetime ES2069030T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45004889A 1989-12-13 1989-12-13

Publications (1)

Publication Number Publication Date
ES2069030T3 true ES2069030T3 (es) 1995-05-01

Family

ID=23786557

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90313614T Expired - Lifetime ES2069030T3 (es) 1989-12-13 1990-12-13 Metodo para tratar funcionamiento defectuoso del corazon.

Country Status (8)

Country Link
EP (1) EP0433074B1 (es)
JP (1) JP3067212B2 (es)
AT (1) ATE114475T1 (es)
CA (1) CA2032079A1 (es)
DE (1) DE69014569T2 (es)
DK (1) DK0433074T3 (es)
ES (1) ES2069030T3 (es)
GR (1) GR3015201T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910484A (en) * 1997-05-30 1999-06-08 The General Hospital Corporation Treatment of ischemic cardiac malfunction
AU7603498A (en) * 1997-05-30 1998-12-30 General Hospital Corporation, The Use of hypothalamic inhibitory factor for treating hypoxia
AU2003279244A1 (en) * 2002-06-20 2004-01-06 The Brigham And Women's Hospital, Inc. Biosynthesis of hif
JP4404087B2 (ja) 2006-11-29 2010-01-27 コニカミノルタビジネステクノロジーズ株式会社 周波数可変クロック出力回路及び同装置、モータ駆動装置びに画像形成装置
CN103439507B (zh) * 2013-08-22 2015-03-25 天津市康婷生物工程有限公司 一种地高辛单抗检测内源性洋地黄样因子含量的试剂盒及使用方法
CN103439485B (zh) * 2013-08-22 2015-01-21 天津市康婷生物工程有限公司 高效检测内源性洋地黄样因子含量的试剂盒及使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305872A (en) * 1979-10-19 1981-12-15 Kenneth Wingrove Polypeptide derivatives
AU614071B2 (en) * 1986-12-09 1991-08-22 Long Island Jewish Medical Center Biologically active agent isolated from human female breast cyst fluid

Also Published As

Publication number Publication date
EP0433074A1 (en) 1991-06-19
DE69014569D1 (de) 1995-01-12
DE69014569T2 (de) 1995-07-13
DK0433074T3 (da) 1995-05-08
ATE114475T1 (de) 1994-12-15
JP3067212B2 (ja) 2000-07-17
JPH0454128A (ja) 1992-02-21
GR3015201T3 (en) 1995-05-31
CA2032079A1 (en) 1991-06-14
EP0433074B1 (en) 1994-11-30

Similar Documents

Publication Publication Date Title
ES2080837T3 (es) Tratamiento de estados y enfermedades.
MX9206817A (es) Nuevos azoheterociclilmetil-cromanos, procedimiento para su obtencion y medicamento que los contiene.
ES2091906T3 (es) Composiciones que comprenden derivados de un peptido de omega-conotoxina y su uso en el tratamiento del daño neuronal relacionado con la isquemia.
AR245226A1 (es) Metodo para mejorar las propiedades del cuero curtido.
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
ES2125233T3 (es) Tratamiento de las infecciones retrovirales humanas con 2',3'-didesoxiinosina.
ES2191192T3 (es) Tienopirimidinas.
ES2057124T3 (es) Producto terapeutico para el tratamiento de estados peri- o post-menopausicos.
ES2156107T3 (es) Un fgf-4 no glicosilado y composiciones que lo contienen.
ES2037013T3 (es) Procedimiento para preparar tieno-1,4-diazepinas.
DE3885096D1 (de) Schneid- und behandlungsanordnung für zylindrische körper, insbesondere für röhren.
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
DE58906239D1 (de) Einrichtung zur Behandlung von Erkrankungen, insbesondere der Sehbahn.
AR002949A1 (es) Análogos del peptido p277 y composiciónes farmaceuticas y preparaciónes que los comprenden para el tratamiento o diagnostico de diabetes y un equipo para diagnosticar.
AR008908A1 (es) Uso de loratadina y un descongestivo para preparar un medicamento para mejorar la funcion pulmonar de un paciente que padece asma
ES2119165T3 (es) Nueva actividad de cofactor anticoagulante.
ES2037808T3 (es) Procedimiento para la obtencion de medicamentos para la profilaxis y terapia de enfermedades producidas por retrovirus.
ES2069030T3 (es) Metodo para tratar funcionamiento defectuoso del corazon.
ES2093714T3 (es) Metodos y composiciones para la deteccion y el tratamiento precoces de la diabetes mellitus insulinodependiente.
ES2052647T3 (es) Procedimiento para la produccion de un preparado combinado farmaceutico.
UY25844A1 (es) Modificación a cristal de una sustancia activa de medicamento
ATE121293T1 (de) Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.
ATE64300T1 (de) Wirkstoffe zur anwendung bei der behandlung von tumoren.
IT8021795A0 (it) Derivati del 5h-furanone-2 e del3h-diidrofuranone-2,loro procedimento di preparazione e loro applicazione terapeutica.
ES2037278T3 (es) Tratamiento de la esterilidad.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 433074

Country of ref document: ES